WallStreetZenWallStreetZen

NASDAQ: BCDA
Biocardia Inc Earnings & Revenue

BCDA past revenue growth

How has BCDA's revenue growth performed historically?
Company
-65.49%
Industry
82.48%
Market
19.08%
BCDA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BCDA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BCDA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BCDA earnings and revenue history

Current Revenue
$468.0k
Current Earnings
-$10.3M
Current Profit Margin
-2,208.8%

BCDA Return on Equity

Current Company
N/A
Current Industry
16.8%
Current Market
28.2%

Be the first to know when BCDA announces earnings.

BCDA Return on Assets

Current Company
-261.7%
Current Industry
3.2%
BCDA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BCDA Return on Capital Employed

Current Company
742.6%
Current Industry
-42.4%
BCDA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BCDA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BCDA$468.00k-$9.92M-$10.34M-6.13%N/A
KTTA$0.00-$15.64M-$16.28M-100.00%N/A
ENVB$0.00-$14.66M-$15.11M-100.00%N/A
VIRI$0.00-$5.07M-$5.07MN/AN/A
CERON/AN/AN/AN/AN/A

BCDA earnings dates

Next earnings date
Aug 7, 2024

Biocardia Earnings & Revenue FAQ

What were BCDA's earnings last quarter?

On Invalid Date, Biocardia (NASDAQ: BCDA) reported Q1 2024 earnings per share (EPS) of -$1.35, up 47.06% year over year. Total Biocardia earnings for the quarter were -$2.27 million. In the same quarter last year, Biocardia's earnings per share (EPS) was -$2.55.

If you're new to stock investing, here's how to buy Biocardia stock.

What was BCDA's earnings growth in the past year?

As of Q2 2024, Biocardia's earnings has grown year over year. Biocardia's earnings in the past year totalled -$10.34 million.

What is BCDA's earnings date?

Biocardia's earnings date is Invalid Date. Add BCDA to your watchlist to be reminded of BCDA's next earnings announcement.

What was BCDA's revenue last quarter?

On Invalid Date, Biocardia (NASDAQ: BCDA) reported Q1 2024 revenue of $55.00 thousand up 14.06% year over year. In the same quarter last year, Biocardia's revenue was $64.00 thousand.

What was BCDA's revenue growth in the past year?

As of Q2 2024, Biocardia's revenue has grown -65.49% year over year. This is 147.97 percentage points lower than the US Biotechnology industry revenue growth rate of 82.48%. Biocardia's revenue in the past year totalled $468.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.